• LAST PRICE
    1.0100
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.9417%)
  • Bid / Lots
    1.0100/ 1
  • Ask / Lots
    1.0300/ 17
  • Open / Previous Close
    1.0200 / 1.0300
  • Day Range
    Low 0.9899
    High 1.0320
  • 52 Week Range
    Low 0.4986
    High 1.9140
  • Volume
    1,292,619
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.03
TimeVolumeSLS
09:32 ET102981.0299
09:34 ET217471.01
09:36 ET715771.0099
09:38 ET192781.0099
09:39 ET110311.005
09:41 ET348271
09:43 ET358080.9948
09:45 ET47980.9946
09:48 ET72960.992399
09:50 ET438131.005
09:52 ET42811.008
09:54 ET2161
09:56 ET5321.005
09:57 ET3251.005
09:59 ET60201.0016
10:01 ET203051
10:03 ET181560.9921
10:06 ET97681
10:10 ET9050.9961
10:12 ET12000.9999
10:14 ET88001
10:15 ET4000.997
10:17 ET166241
10:19 ET70250.9999
10:21 ET4500.995
10:24 ET4010.997
10:28 ET59620.999
10:30 ET85561
10:32 ET19501.005
10:33 ET44381
10:37 ET17421.005
10:39 ET25001.01
10:44 ET10001.01
10:46 ET23051
10:48 ET317760.9985
10:50 ET25790.998
10:55 ET50001
10:57 ET41191.0015
11:02 ET7001.005
11:04 ET83441.01
11:06 ET26001.005
11:08 ET22001.01
11:09 ET57931.005
11:13 ET131601.005
11:15 ET140831.005
11:18 ET18001.0097
11:20 ET21901.005
11:22 ET405511.005
11:24 ET4601.005
11:27 ET30001.005
11:29 ET16631.01
11:31 ET20001.005
11:36 ET3471.0086
11:44 ET3701.01
11:45 ET1001
11:47 ET253881.01
11:49 ET31001.01
11:51 ET29001.005
11:54 ET1001.01
11:56 ET18261
12:00 ET10581.01
12:02 ET138471.0003
12:03 ET9881.01
12:07 ET108761.01
12:09 ET2381.01
12:12 ET3081.01
12:14 ET6001.005
12:18 ET35501.0099
12:20 ET44001.005
12:21 ET12001
12:23 ET74001.005
12:25 ET904241.01
12:27 ET59001.01
12:30 ET246241.005
12:32 ET112201.01
12:34 ET10001.0092
12:38 ET259130.997
12:39 ET29061
12:41 ET1201
12:43 ET38151.01
12:45 ET38061.005
12:48 ET9571.005
12:52 ET17691.01
12:54 ET1001.01
12:56 ET8001.0083
12:57 ET30001
01:01 ET11001.005
01:03 ET7001.0099
01:06 ET11001
01:12 ET20151.01
01:14 ET73571.005
01:17 ET21001.005
01:21 ET158201.005
01:24 ET125201.0004
01:26 ET10001.005
01:30 ET37391
01:32 ET152491.005
01:33 ET10001.005
01:35 ET186001.01
01:37 ET1001.005
01:39 ET131751.0001
01:42 ET10001
01:44 ET54001.005
01:46 ET104801.005
01:48 ET145781
01:50 ET5001.005
01:51 ET27401.005
01:53 ET37581
02:00 ET191121
02:02 ET15321
02:04 ET1001.005
02:06 ET1001.01
02:08 ET62011.0001
02:09 ET42681.005
02:11 ET46001.01
02:13 ET2001.01
02:18 ET5261.01
02:22 ET117241.005
02:24 ET7001.005
02:27 ET5001
02:33 ET8001.005
02:36 ET44001.005
02:38 ET30001.0094
02:40 ET2001.005
02:42 ET9951.005
02:45 ET11351.0014
02:47 ET18981.005
02:49 ET59001.005
02:54 ET207571.01
02:56 ET6941.0099
03:02 ET108351
03:03 ET10001.01
03:05 ET114041
03:12 ET24951.009
03:16 ET19801.01
03:18 ET130381.01
03:20 ET4001.01
03:23 ET34551.005
03:25 ET10001.01
03:34 ET1001.0099
03:39 ET1001.01
03:41 ET17761.005
03:43 ET5121
03:45 ET2111.0004
03:48 ET26171
03:50 ET36061.0083
03:52 ET105041.005
03:54 ET37201
03:57 ET15201.01
03:59 ET134901.01
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSLS
Sellas Life Sciences Group Inc
55.7M
-0.7x
---
United StatesCLNN
Clene Inc.
54.6M
-0.8x
---
United StatesRPHM
Reneo Pharmaceuticals Inc
55.3M
-0.7x
---
United StatesVNRX
VolitionRX Ltd
62.1M
-1.5x
---
United StatesAVRO
AVROBIO Inc
57.4M
4.6x
---
United StatesUNCY
Unicycive Therapeutics Inc
48.0M
-0.8x
---
As of 2024-03-29

Company Information

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of novel therapeutics for a range of cancer indications. The Company's product candidates, galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9), inhibitor. GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed from GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of Greater China.

Contact Information

Headquarters
7 TIMES SQUARE, SUITE 2503NEW YORK, NY, United States 10036
Phone
646-200-5278
Fax
925-498-7799

Executives

Independent Chairman of the Board
Jane Wasman
President, Chief Executive Officer, Director
Angelos Stergiou
Chief Financial Officer
John Burns
Executive Vice President, General Counsel, Corporate Secretary
Barbara Wood
Senior Vice President - Clinical Development
Dragan Cicic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$55.7M
Revenue (TTM)
$0.00
Shares Outstanding
55.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.36
EPS
$-1.55
Book Value
$0.23
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.